AIM ImmunoTech (AIM) Stock Price
AIM ImmunoTech Price
Revenue at AIM ImmunoTech has contracted by 11.7% per year over the past 19 years to 88,000.00 USD. For AIM ImmunoTech, the net margin of -15,861.4% is down versus -14,168.1% a few years ago.
AIM ImmunoTech stock price
AIM ImmunoTech business model & stock analysis
Frequently asked questions about AIM ImmunoTech
6 analysts currently rate the AIM ImmunoTech stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect AIM ImmunoTech to generate revenue of 74,000.00 USD and earnings per share of -0.14 USD.
Converted at the current exchange rate, the AIM ImmunoTech share trades at 0.16 EUR (0.18 USD).
The AIM ImmunoTech share (AIM) is listed on 5 stock exchanges, including: London (0A4Y.L), Frankfurt (HXB2.F), München (HXB2.MU), Düsseldorf (HXB2.DU).
The expected revenue of AIM ImmunoTech is 74,000.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of AIM ImmunoTech is -436,955.96 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of AIM ImmunoTech is currently -1.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the AIM ImmunoTech stock.
The price-to-sales ratio (P/S) of AIM ImmunoTech is currently 7.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the AIM ImmunoTech stock.
The Eulerpool Quality Score for AIM ImmunoTech is 2/10.
The ISIN of AIM ImmunoTech is US00901B3033. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of AIM ImmunoTech is A2PREX. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of AIM ImmunoTech is AIM. The ticker symbol is used to trade AIM ImmunoTech shares on the stock exchange.
AIM ImmunoTech stock
AIM ImmunoTech Peer Group
AIM ImmunoTech Ticker
All fundamentals and in-depth analysis of AIM ImmunoTech
Our stock analysis for AIM ImmunoTech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AIM ImmunoTech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.